DaVita Inc. (NYSE:DVA) Shares Purchased by iA Global Asset Management Inc.

iA Global Asset Management Inc. boosted its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 157.0% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 14,924 shares of the company's stock after buying an additional 9,118 shares during the period. iA Global Asset Management Inc.'s holdings in DaVita were worth $2,283,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. UMB Bank n.a. lifted its stake in shares of DaVita by 65.5% during the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after acquiring an additional 76 shares during the last quarter. Copia Wealth Management purchased a new stake in DaVita in the fourth quarter valued at about $30,000. Coppell Advisory Solutions LLC increased its stake in DaVita by 50.0% during the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock valued at $45,000 after purchasing an additional 100 shares in the last quarter. Canada Post Corp Registered Pension Plan purchased a new position in shares of DaVita in the fourth quarter worth about $55,000. Finally, GeoWealth Management LLC boosted its holdings in shares of DaVita by 30.6% in the 4th quarter. GeoWealth Management LLC now owns 525 shares of the company's stock valued at $79,000 after acquiring an additional 123 shares during the last quarter. 90.12% of the stock is owned by institutional investors.

DaVita Price Performance

Shares of DaVita stock traded up $1.86 on Friday, hitting $129.55. 949,567 shares of the company were exchanged, compared to its average volume of 883,366. DaVita Inc. has a 1-year low of $126.07 and a 1-year high of $179.60. The stock has a market capitalization of $9.26 billion, a price-to-earnings ratio of 12.74, a price-to-earnings-growth ratio of 0.88 and a beta of 1.09. The company has a quick ratio of 1.20, a current ratio of 1.39 and a debt-to-equity ratio of 23.18. The company has a 50-day moving average price of $140.02 and a 200 day moving average price of $146.79.

DaVita (NYSE:DVA - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, topping the consensus estimate of $2.70 by $0.25. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The company had revenue of $3.38 billion during the quarter, compared to analyst estimates of $3.36 billion. During the same quarter last year, the firm posted $2.00 earnings per share. DaVita's revenue was up 6.1% compared to the same quarter last year. As a group, sell-side analysts predict that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Insider Transactions at DaVita

In related news, insider James O. Hearty sold 2,351 shares of the stock in a transaction on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the transaction, the insider owned 26,038 shares of the company's stock, valued at $3,905,700. This represents a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 2.00% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on DVA shares. Barclays cut their price target on DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a research note on Thursday. Truist Financial set a $148.00 price target on shares of DaVita in a research report on Friday. Finally, Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a research note on Friday, April 25th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $166.75.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.